PE20120991A1 - Antagonista del receptor opiaceo para los trastornos del tracto gastrointestinal - Google Patents
Antagonista del receptor opiaceo para los trastornos del tracto gastrointestinalInfo
- Publication number
- PE20120991A1 PE20120991A1 PE2012000347A PE2012000347A PE20120991A1 PE 20120991 A1 PE20120991 A1 PE 20120991A1 PE 2012000347 A PE2012000347 A PE 2012000347A PE 2012000347 A PE2012000347 A PE 2012000347A PE 20120991 A1 PE20120991 A1 PE 20120991A1
- Authority
- PE
- Peru
- Prior art keywords
- opious
- disorders
- gastrointestinal tract
- receptor antagonist
- opiaceous
- Prior art date
Links
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000036592 analgesia Effects 0.000 abstract 1
- 230000005993 intestine dysfunction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Abstract
REFERIDA AL COMPUESTO 5-(2-METOXI-4-{[2-(TETRAHIDRO-PIRAN-4-IL)-ETILAMINO]-METIL}-FENOXI)-PIRAZIN-2-CARBOXAMIDA (COMPUESTO I) EL CUAL ES UN ANTAGONISTA DEL RECEPTOR OPIACEO Y ES UTIL EN EL TRATAMIENTO DEL ESTRENIMIENTO INDUCIDO POR OPIACEOS O DISFUNCION DEL INTESTINO INDUCIDA POR OPIACEOS SIN REDUCIR LA ANALGESIA DEL OPIACEO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24361609P | 2009-09-18 | 2009-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120991A1 true PE20120991A1 (es) | 2012-08-01 |
Family
ID=43216894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000347A PE20120991A1 (es) | 2009-09-18 | 2010-09-17 | Antagonista del receptor opiaceo para los trastornos del tracto gastrointestinal |
Country Status (19)
Country | Link |
---|---|
US (1) | US20110071163A1 (es) |
EP (1) | EP2477627B1 (es) |
JP (1) | JP5797655B2 (es) |
KR (1) | KR20120092592A (es) |
CN (2) | CN102695508A (es) |
AU (1) | AU2010295464B2 (es) |
BR (1) | BR112012006069A8 (es) |
CA (1) | CA2774021A1 (es) |
CL (1) | CL2012000676A1 (es) |
CO (1) | CO6531453A2 (es) |
HK (1) | HK1210959A1 (es) |
IL (1) | IL218679A0 (es) |
MX (1) | MX342548B (es) |
NZ (1) | NZ598783A (es) |
PE (1) | PE20120991A1 (es) |
RU (1) | RU2561873C2 (es) |
TW (1) | TW201118084A (es) |
WO (1) | WO2011035142A1 (es) |
ZA (1) | ZA201201954B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2548782T3 (es) | 2012-12-28 | 2015-10-20 | Instytut Medycyny Doswiadczalnej I Klinicznej Im Miroslawa Mossakowskiego Polskiej Akademii Nauk | Peptidomiméticos y su aplicación |
ES2823588T3 (es) | 2016-05-20 | 2021-05-07 | Esteve Pharmaceuticals Sa | Derivados de tetrahidropirano que tienen actividad multimodal contra el dolor |
CN106117190B (zh) * | 2016-06-21 | 2019-03-29 | 山东川成医药股份有限公司 | 一种倍福普兰的合成方法 |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191771A (en) * | 1974-09-06 | 1980-03-04 | Eli Lilly And Company | Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines |
US5166174A (en) * | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
US4992450A (en) * | 1987-04-16 | 1991-02-12 | Eli Lilly And Company | Piperidine opioid antagonists |
US4891379A (en) * | 1987-04-16 | 1990-01-02 | Kabushiki Kaisha Kobe Seikosho | Piperidine opioid antagonists |
US5064834A (en) * | 1987-04-16 | 1991-11-12 | Eli Lilly And Company | Piperidine opioid antagonists |
US5319087A (en) * | 1987-04-16 | 1994-06-07 | Eli Lilly And Company | Piperidine opioid antagonists |
US5250542A (en) * | 1991-03-29 | 1993-10-05 | Eli Lilly And Company | Peripherally selective piperidine carboxylate opioid antagonists |
US5159081A (en) * | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
US5270328A (en) * | 1991-03-29 | 1993-12-14 | Eli Lilly And Company | Peripherally selective piperidine opioid antagonists |
US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
DE69535432T2 (de) | 1994-04-22 | 2007-12-06 | Astellas Pharma Inc. | Kolon-spezifisches Arzneistofffreisetzungssystem |
US5378448A (en) * | 1994-06-07 | 1995-01-03 | Lin; Hsing K. | Process for removing selenium from sulfur |
TW490465B (en) * | 1994-11-24 | 2002-06-11 | Janssen Pharmaceutica Nv | Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof |
EP0827746B1 (en) * | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
US6559158B1 (en) * | 1997-11-03 | 2003-05-06 | Ur Labs, Inc. | Use of methylnaltrexone and related compounds to treat chronic opioid use side affects |
US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
WO2000018377A1 (en) | 1998-09-28 | 2000-04-06 | Warner-Lambert Company | Enteric and colonic delivery using hpmc capsules |
US6436959B1 (en) * | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
US6194382B1 (en) * | 1999-03-03 | 2001-02-27 | Albert Einstein College Of Medicine Of Yeshiva University | Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists |
DK1220849T3 (da) * | 1999-10-15 | 2004-09-27 | Sucampo Ag | Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf |
CZ299726B6 (cs) * | 1999-11-01 | 2008-11-05 | Lécivo pro lécení zácpy a syndromu dráždivého tracníku | |
US6469030B2 (en) * | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
US6414016B1 (en) * | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
ATE391712T1 (de) * | 2000-10-31 | 2008-04-15 | Rensselaer Polytech Inst | 4-arylpiperidine als opioidrezeptorbindende agenzien |
WO2003030912A1 (en) * | 2001-08-31 | 2003-04-17 | Sucampo Ag | Prostaglandin analogs as chloride channel opener |
WO2003032990A2 (en) * | 2001-10-18 | 2003-04-24 | Nektar Therapeutics Al, Corporation | Polymer conjugates of opioid antagonists |
TWI331920B (en) * | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
PL212616B1 (pl) * | 2002-09-19 | 2012-10-31 | Lilly Co Eli | Eter diarylowy i kompozycja farmaceutyczna zawierajaca ten eter |
TWI336254B (en) * | 2002-12-27 | 2011-01-21 | Sucampo Ag | Pharmaceutical composition for treating abdominal discomfort |
AU2004220113A1 (en) * | 2003-03-07 | 2004-09-23 | Eli Lilly And Company | Opioid receptor antagonists |
AU2004303790A1 (en) * | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Opioid receptor antagonists |
EP1699783B1 (en) * | 2003-12-22 | 2012-07-25 | Eli Lilly And Company | Opioid receptor antagonists |
ATE399164T1 (de) * | 2004-03-12 | 2008-07-15 | Lilly Co Eli | Antagonisten des opioidrezeptors |
EP1727788B1 (en) * | 2004-03-12 | 2010-07-28 | Eli Lilly And Company | Opioid receptor antagonists |
US8524731B2 (en) * | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
WO2006126529A1 (ja) * | 2005-05-25 | 2006-11-30 | Shionogi & Co., Ltd. | 6,7-不飽和-7-カルバモイル置換モルヒナン誘導体 |
US8026393B2 (en) * | 2006-01-24 | 2011-09-27 | Sucampo Ag | Soft-gelatin capsule formulation |
MY145633A (en) * | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
TWI409067B (zh) * | 2007-02-28 | 2013-09-21 | Theravance Inc | 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型 |
WO2009051824A2 (en) * | 2007-10-18 | 2009-04-23 | Aiko Biotechnology | Combination analgesic employing opioid and neutral antagonist |
MY149973A (en) * | 2007-12-11 | 2013-11-15 | Theravance Inc | 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists |
CA2745441C (en) * | 2008-12-10 | 2017-10-17 | Theravance, Inc. | Crystalline forms of a 3-carboxypropyl-aminotetralin compound |
WO2011068594A1 (en) * | 2009-12-04 | 2011-06-09 | Alkermes, Inc. | Morphinan derivatives for the treatment of drug overdose |
-
2010
- 2010-09-17 TW TW099131769A patent/TW201118084A/zh unknown
- 2010-09-17 AU AU2010295464A patent/AU2010295464B2/en not_active Ceased
- 2010-09-17 NZ NZ598783A patent/NZ598783A/xx not_active IP Right Cessation
- 2010-09-17 WO PCT/US2010/049311 patent/WO2011035142A1/en active Application Filing
- 2010-09-17 US US12/884,985 patent/US20110071163A1/en not_active Abandoned
- 2010-09-17 MX MX2012003310A patent/MX342548B/es active IP Right Grant
- 2010-09-17 EP EP10757144.0A patent/EP2477627B1/en not_active Not-in-force
- 2010-09-17 BR BR112012006069A patent/BR112012006069A8/pt not_active Application Discontinuation
- 2010-09-17 RU RU2012115450/15A patent/RU2561873C2/ru not_active IP Right Cessation
- 2010-09-17 KR KR1020127008846A patent/KR20120092592A/ko not_active Application Discontinuation
- 2010-09-17 PE PE2012000347A patent/PE20120991A1/es not_active Application Discontinuation
- 2010-09-17 CA CA2774021A patent/CA2774021A1/en not_active Abandoned
- 2010-09-17 CN CN2010800522092A patent/CN102695508A/zh active Pending
- 2010-09-17 CN CN201510256187.6A patent/CN104958298A/zh active Pending
- 2010-09-17 JP JP2012529934A patent/JP5797655B2/ja not_active Expired - Fee Related
-
2012
- 2012-03-15 ZA ZA2012/01954A patent/ZA201201954B/en unknown
- 2012-03-15 IL IL218679A patent/IL218679A0/en unknown
- 2012-03-16 CL CL2012000676A patent/CL2012000676A1/es unknown
- 2012-04-18 CO CO12064152A patent/CO6531453A2/es not_active Application Discontinuation
-
2015
- 2015-12-02 HK HK15111842.0A patent/HK1210959A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL218679A0 (en) | 2012-05-31 |
AU2010295464B2 (en) | 2015-11-26 |
JP2013505260A (ja) | 2013-02-14 |
CN102695508A (zh) | 2012-09-26 |
ZA201201954B (en) | 2012-11-28 |
BR112012006069A8 (pt) | 2017-10-10 |
MX2012003310A (es) | 2012-07-17 |
BR112012006069A2 (pt) | 2016-03-29 |
TW201118084A (en) | 2011-06-01 |
EP2477627A1 (en) | 2012-07-25 |
JP5797655B2 (ja) | 2015-10-21 |
AU2010295464A1 (en) | 2012-04-12 |
RU2012115450A (ru) | 2013-10-27 |
US20110071163A1 (en) | 2011-03-24 |
RU2561873C2 (ru) | 2015-09-10 |
EP2477627B1 (en) | 2018-08-15 |
CL2012000676A1 (es) | 2012-10-19 |
CA2774021A1 (en) | 2011-03-24 |
CN104958298A (zh) | 2015-10-07 |
MX342548B (es) | 2016-10-04 |
NZ598783A (en) | 2013-07-26 |
KR20120092592A (ko) | 2012-08-21 |
WO2011035142A1 (en) | 2011-03-24 |
HK1210959A1 (en) | 2016-05-13 |
CO6531453A2 (es) | 2012-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170151A1 (ru) | Пиперидиниловые агонисты gpcr | |
EA200900878A1 (ru) | Пиперидиновые агонисты gpcr | |
EA200900879A1 (ru) | Пиперидиновые агонисты gpcr | |
EA200900796A1 (ru) | Пиперидиновые агонисты gpcr | |
EA200900880A1 (ru) | Пиперидиновые агонисты gpcr | |
MX342161B (es) | Compuestos antagonistas selectivos de receptor nk-3 novedosos, composicion farmaceutica y metodos para utilizarse en trastornos transmitidos por receptores nk-3. | |
ECSP12011606A (es) | Agonistas de gpr119 | |
GB0812642D0 (en) | Compounds | |
MY169479A (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
EA201000113A1 (ru) | Пиразольные соединения | |
HK1158192A1 (en) | Piperidine gpcr agonists | |
EA201290394A1 (ru) | Морфолинотиазолы в качестве позитивных аллостерических модуляторов альфа 7 | |
EA200801897A1 (ru) | Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений | |
EA200900877A1 (ru) | Пиперидиновые агонисты gpcr | |
EA201200019A1 (ru) | Соединения, которые селективно модулируют рецептор св2 | |
EA201290355A1 (ru) | Спиропиперидиновые соединения в качестве антагонистов рецептора orl-1 | |
EA201390683A1 (ru) | Пиперидинонкарбоксамидазаинданы - антагонисты рецептора cgrp | |
NO20085051L (no) | Behandling av gastrointestinale forstyrrelser med CGRP-antagonister | |
EA201190207A1 (ru) | Соединения для лечения метаболических расстройств | |
CL2011001848A1 (es) | Compuestos derivados de pirimidina fusionada a un heterociclo de 5 miembros; antagonista del receptor de angiotensina ii, agonista del receptor de proliferador de peroxisomas; composicion farmaceutica; y uso de los compuestos en el tratamiento de enfermedades circulatorias tales como hipertension, enfermedad cardiaca, arteriosclerosis, entre otras. | |
EA201591391A1 (ru) | Производное 2-ациламинотиазола или его соль | |
EA201270428A1 (ru) | Замещенные n-фенил-1-(4-пиридинил)-1н-пиразол-3-амины | |
FR2969738B1 (fr) | Joint filete pour le forage et l'exploitation des puits d'hydrocarbures | |
PE20120991A1 (es) | Antagonista del receptor opiaceo para los trastornos del tracto gastrointestinal | |
WO2011151436A3 (en) | Azepin-derivatives as derivatives as g- protein coupled receptor (gpr43) agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |